文献速递糖尿病

1型糖尿病妊娠期糖尿病视网膜病变的进展及预测因素:499例妊娠报告

Progression of Diabetic Retinopathy and Predictors of Its Development and Progression During Pregnancy in Patients With Type 1 Diabetes: A Report of 499 Pregnancies.
PubMed 文献 · Diabetes Care · 2020-11-11

该研究回顾性分析了法国里尔1997至2015年375例1型糖尿病患者的499次妊娠,评估妊娠期糖尿病视网膜病变(DR)的进展率及预测因素。结果显示,孕前视网膜病变患病率为30.3%,进展率21.8%,无视网膜病变者新发率24.4%,有病变者恶化率15.9%。孕前HbA1c升高和糖尿病病程≥10年是DR进展的预测因素。

要点

  • 孕前视网膜病变患病率30.3%,妊娠期DR进展率21.8%。
  • 孕前HbA1c升高和糖尿病病程≥10年可预测DR进展。
  • 产后随访者中进展率仅4.1%,回归率9.3%。

核心结论

  • 妊娠期DR进展率21.8%,主要发生在妊娠早期或中期,威胁视力的视网膜病变发展罕见。

研究设计与样本

  • 回顾性研究,纳入法国里尔1997至2015年375例1型糖尿病患者的499次妊娠,每3个月或每月进行眼科检查。

主要发现

  • 孕前视网膜病变患病率为30.3%。
  • 总进展率21.8%,无视网膜病变者新发率24.4%,有视网膜病变者恶化率15.9%。
  • 孕前HbA1c升高和糖尿病病程≥10年是DR进展的预测因素。
  • 在有孕前DR的妊娠中,持续皮下胰岛素输注(CSII)趋于降低DR进展风险。
  • 在270例产后返回眼科检查的妊娠中,进展率仅4.1%,回归率9.3%。

关键数值与推荐

  • 进展定义为DR恶化≥1个早期治疗糖尿病视网膜病变研究(ETDRS)分类阶段。

临床怎么用

  • 对于1型糖尿病妊娠患者,应关注孕前HbA1c和糖尿病病程以评估DR进展风险。
  • 妊娠期应定期进行眼科检查,尤其对于孕前已有视网膜病变者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Pregnancy has been associated with development and progression of diabetic retinopathy (DR), but incidence of DR remains unclear. We assessed DR progression rate and its predictors during pregnancies in patients with type 1 diabetes. RESEARCH DESIGN AND METHODS: We report the retrospective data from pregnancies in patients with type 1 diabetes followed in Lille, France (1997-2015). Eye examination was performed every 3 months or every month in case of severe nonproliferative retinopathy or progression. Progression was defined by DR degradation (≥1 stage of the Early Treatment Diabetic Retinopathy Study [ETDRS] classification); it included DR development and worsening in patients without and with prepregnancy DR, respectively. RESULTS: A total of 499 pregnancies in 375 patients were included; prepregnancy retinopathy was present in 30.3%. Progression, development, and worsening rates were 21.8%, 24.4% of those without retinopathy, and 15.9% of those with retinopathy, respectively. Development of sight-threatening retinopathy was rare. Progression mainly occurred in early or midpregnancy. Elevated prepregnancy HbA1c and duration of diabetes ≥10 years were predictors of DR progression. Among pregnancies with prepregnancy DR, continuous subcutaneous insulin infusion (CSII) tended to decrease the risk of DR progression. Among CSII-treated patients, those with prepregnancy DR had a significantly decreased risk of DR progression. Among the 270 pregnancies of women with any DR during pregnancy who returned for a postpartum ophthalmologic examination, the rate of progression was only 4.1% and the rate of regression was 9.3%. CONCLUSIONS: This study provides epidemiologic data on progression of retinopathy during pregnancy and will be useful for future guidelines for retinopathy screening.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Bourry J, Courteville H, Ramdane N, et al. Progression of Diabetic Retinopathy and Predictors of Its Development and Progression During Pregnancy in Patients With Type 1 Diabetes: A Report of 499 Pregnancies. Diabetes Care. 2020. PMID: 33177172. doi:10.2337/dc20-0904

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。